The promising results of two MAPS-sponsored observational studies into treating opioid dependence with ibogaine, a naturally occurring psychedelic compound, have been published in the peer-reviewed American Journal of Drug and Alcohol Abuse. Both studies show that ibogaine should be further studied as a potential treatment for opioid dependence through rigorously controlled studies. Read the Press Release…
